Monthly Archives: September 2017
Comprehensive Epilepsy Panel
Comprehensive Muscular Dystrophy/Myopathy Panel
Comprehensive Intellectual Disabilty Panel
Ataxia/Episodic Ataxia Panel
Spastic Paraplegia PanelWe strive to give you the best answers possible when you trust us with your patients’ samples and endeavor to provide you with actionable results. Utilizing our proprietary Genome MaNaGer™ pipeline and Neurogenetic Answers™ reporting process, we aim to reduce the distraction of unrelated variants of uncertain significance.
Date and Time:
Wednesday, September 13th 6:30PM-7:00PM
Chief Medical Officer, Dr. Peter L. Nagy, MD, PhD Genetic Counselor, Ymkje Cuperus, MS
MNG Laboratories will present multiple case studies in which comprehensive testing methods incorporated into our next-generation sequencing test offerings, such as copy number assessment, mitochondrial genome sequencing with deletion analysis, and repeat expansion testing, can increase clinical sensitivity of genetic testing.